Mark H. Lee

2.2k total citations
44 papers, 1.5k citations indexed

About

Mark H. Lee is a scholar working on Oncology, Artificial Intelligence and Social Psychology. According to data from OpenAlex, Mark H. Lee has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Artificial Intelligence and 6 papers in Social Psychology. Recurrent topics in Mark H. Lee's work include Social Robot Interaction and HRI (6 papers), Robot Manipulation and Learning (4 papers) and Child and Animal Learning Development (4 papers). Mark H. Lee is often cited by papers focused on Social Robot Interaction and HRI (6 papers), Robot Manipulation and Learning (4 papers) and Child and Animal Learning Development (4 papers). Mark H. Lee collaborates with scholars based in South Korea, United Kingdom and United States. Mark H. Lee's co-authors include H.R. Nicholls, Robert T. Means, Kihyun Kım, Keunchil Park, Chul Won Jung, Won Ki Kang, Joon Oh Park, Young‐Hyuck Im, Young Hyuck Im and Fei Chao and has published in prestigious journals such as Clinical Cancer Research, Biochemical and Biophysical Research Communications and The American Journal of Medicine.

In The Last Decade

Mark H. Lee

43 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark H. Lee South Korea 19 430 294 260 216 205 44 1.5k
Ángel Rubio Spain 24 225 0.5× 1.2k 4.0× 133 0.5× 206 1.0× 252 1.2× 70 2.1k
Nobuaki Kobayashi Japan 14 74 0.2× 228 0.8× 221 0.8× 190 0.9× 240 1.2× 174 1.2k
Jingrong Li China 25 97 0.2× 755 2.6× 246 0.9× 315 1.5× 35 0.2× 73 2.0k
Toru Tanaka Japan 31 594 1.4× 622 2.1× 130 0.5× 194 0.9× 222 1.1× 185 4.5k
Xuening Zhang China 25 692 1.6× 369 1.3× 18 0.1× 181 0.8× 157 0.8× 101 2.0k
Ning Cong China 20 149 0.3× 368 1.3× 49 0.2× 100 0.5× 47 0.2× 99 1.5k
Yushan Chen China 24 76 0.2× 869 3.0× 55 0.2× 152 0.7× 51 0.2× 139 2.1k
Haoyu Wu China 24 277 0.6× 639 2.2× 32 0.1× 86 0.4× 57 0.3× 102 1.8k
Jiajie Yu China 21 870 2.0× 328 1.1× 45 0.2× 453 2.1× 24 0.1× 68 1.7k

Countries citing papers authored by Mark H. Lee

Since Specialization
Citations

This map shows the geographic impact of Mark H. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Lee more than expected).

Fields of papers citing papers by Mark H. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Lee. The network helps show where Mark H. Lee may publish in the future.

Co-authorship network of co-authors of Mark H. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Lee. A scholar is included among the top collaborators of Mark H. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Lee. Mark H. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, Steven R., Suzanne L. Epstein, Ross W. Filice, et al.. (2013). Continuing to strengthen FDA's science approach to emerging technologies. Nanomedicine Nanotechnology Biology and Medicine. 9(5). 594–599. 8 indexed citations
2.
Kim, Seung Tae, Mark H. Lee, Sung‐Yong Kim, et al.. (2010). A randomized trial of preemptive therapy for prevention of cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 91(5). 886–891. 9 indexed citations
3.
Lee, Mark H., et al.. (2009). Considerations for Tissue-Engineered and Regenerative Medicine Product Development Prior to Clinical Trials in the United States. Tissue Engineering Part B Reviews. 16(1). 41–54. 94 indexed citations
4.
Park, Chan H., Bruce F. Kimler, Seong Yoon Yi, et al.. (2009). Depletion of l‐ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromes. European Journal Of Haematology. 83(2). 108–118. 17 indexed citations
5.
Dabros, Michal, David J. Currie, Mark H. Lee, et al.. (2008). Cole–Cole, linear and multivariate modeling of capacitance data for on-line monitoring of biomass. Bioprocess and Biosystems Engineering. 32(2). 161–173. 59 indexed citations
6.
Lee, Mark H., Qinggang Meng, & Fei Chao. (2006). Developmental Robotics from Developmental Psychology. Loughborough University Institutional Repository (Loughborough University).
7.
Han, Seong‐Su, Kihyun Kım, Eun‐Ryeong Hahm, et al.. (2004). L‐ascorbic acid represses constitutive activation of NF‐κB and COX‐2 expression in human acute myeloid leukemia, HL‐60. Journal of Cellular Biochemistry. 93(2). 257–270. 38 indexed citations
8.
Lee, Jeeyun, Mark H. Lee, Won Seog Kim, et al.. (2004). Tuberculosis in Hematopoietic Stem Cell Transplant Recipients in Korea. International Journal of Hematology. 79(2). 185–188. 30 indexed citations
9.
Park, Se Hoon, Won Ki Kang, Jinny Park, et al.. (2004). Docetaxel Plus Cisplatin as Second-Line Therapy in Metastatic or Recurrent Advanced Gastric Cancer Progressing on 5-Fluorouracil-Based Regimen. American Journal of Clinical Oncology. 27(5). 477–480. 38 indexed citations
10.
Jee, Yong‐Seok, Joon Oh Park, Won Seog Kim, et al.. (2004). Phase II Study of Gemcitabine Combined with Uracil-Tegafur in Metastatic Pancreatic Cancer. Oncology. 66(1). 32–37. 17 indexed citations
11.
Jee, Yong‐Seok, Won Gu Kim, Kihyun Kım, et al.. (2003). Intestinal Lymphoma: Exploration of the Prognostic Factors and the Optimal Treatment. Leukemia & lymphoma. 45(2). 339–344. 41 indexed citations
12.
Park, Woo Hyun, Yeon Hee Cho, Chul Won Jung, et al.. (2003). Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochemical and Biophysical Research Communications. 300(1). 230–235. 110 indexed citations
14.
Lee, Mark H., et al.. (2002). The Implications of Philosophical Foundations for Knowledge Representation and Learning in Agents.. Adaptive Agents and Multi-Agents Systems. 216–238. 1 indexed citations
15.
Kım, Kihyun, Mark H. Lee, Jingook Kim, et al.. (2002). Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. American Journal of Hematology. 71(2). 75–79. 51 indexed citations
16.
Kım, Kihyun, Eunmi Nam, Nam Soo Lee, et al.. (2002). Oxaliplatin and UFT Combination Chemotherapy in Patients With Metastatic Colorectal Cancer. American Journal of Clinical Oncology. 25(4). 354–357. 13 indexed citations
17.
Lee, Mark H., et al.. (2001). The effect of end groups on thermodynamics of immiscible polymer blends. 2. Cloud point curves. Polymer. 42(21). 9163–9172. 20 indexed citations
18.
Lee, Mark H.. (2000). Qualitative modelling of linear networks in engineering applications. European Conference on Artificial Intelligence. 161–165. 2 indexed citations
19.
Lee, Mark H. & Robert T. Means. (1995). Extremely elevated serum ferritin levels in a university hospital: Associated diseases and clinical significance. The American Journal of Medicine. 98(6). 566–571. 122 indexed citations
20.
Nicholls, H.R. & Mark H. Lee. (1989). A Survey of Robot Tactile Sensing Technology. The International Journal of Robotics Research. 8(3). 3–30. 247 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026